InvestorsHub Logo
Followers 4
Posts 372
Boards Moderated 0
Alias Born 08/13/2019

Re: jessellivermore post# 212757

Thursday, 09/05/2019 11:07:05 AM

Thursday, September 05, 2019 11:07:05 AM

Post# of 425892

Atom....

Please understand 4.8% of 4000 patients may not be a huge number 196 events..But Vascepa is not going to be restricted to 4000 patients...Say Vasepa is treating 80,000,000 patients (Vascepa's target. pop) then 4.8% is about 4 mil events...

Comprendez-vous???

":>) JL



First, I think the estimate was closer to 70 million.

Source: https://www.sec.gov/Archives/edgar/data/897448/000119312511217355/dex991.htm

Second, it was an optimistic estimate and likely at the high end of the range.

Third, it would take time (definitely not within the 3-4 month delay) to reach a fraction of that population.

Fourth, based on yesterday's fireside chat, whether Amarin has the capacity to supply a fraction of that population is questionable.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News